Deakin University
Browse

A clinician referral and 12-week exercise training program for men with prostate cancer: outcomes to 12 months of the ENGAGE cluster randomized controlled trial

Version 2 2024-06-03, 20:46
Version 1 2017-04-04, 16:01
journal contribution
posted on 2024-06-03, 20:46 authored by Cadeyrn Gaskin, M Craike, Mohammadreza MohebbiMohammadreza Mohebbi, KS Courneya, Trish LivingstonTrish Livingston
BACKGROUND: The ENGAGE (efficacy of a referral and physical activity program for survivors of prostate cancer) study established that a clinician referral and 12-week exercise training program increased vigorous physical activity at 12 weeks among men with prostate cancer. Here, we report the 6- and 12-month outcomes. METHODS: In this multicenter cluster randomized controlled trial, we compared a clinician referral and exercise training program to usual care. Discounted gym membership was offered to men in the intervention condition on completion of the 12-week exercise program. Self-reported physical activity at 6 and 12 months was the primary outcome. Quality of life, anxiety, and depressive symptoms were secondary outcomes. RESULTS: A total of 147 men meeting eligibility criteria agreed to participate (54 intervention, 93 control). A positive interaction effect for vigorous physical activity was observed at 6 months, but not 12 months. No significant effects for the secondary outcomes were found. CONCLUSIONS: A clinician referral and community-based supervised and unsupervised exercise training program, along with discounted gym membership, had a positive short-term effect on vigorous physical activity levels, but did not improve quality of life, in men with prostate cancer.

History

Journal

Journal of physical activity and health

Volume

14

Pagination

353-359

Location

Champaign, Ill.

ISSN

1543-3080

eISSN

1543-5474

Language

eng

Publication classification

C Journal article, C1 Refereed article in a scholarly journal

Copyright notice

2017, Human Kinetics, Inc.

Issue

5

Publisher

Human Kinetics, Inc.